May 15, 2020 / 5:45 AM / 16 days ago

BRIEF-Transgene Says Data Confirms High Accuracy Of Cancer Vaccine TG4050

May 15 (Reuters) - TRANSGENE SA:

* TRANSGENE AND NEC DEMONSTRATE HIGH ACCURACY OF AI-BASED NEOANTIGEN PREDICTION FOR THE DESIGN OF INDIVIDUALIZED CANCER VACCINE TG4050

* DATA CONFIRM THAT PREDICTION ALGORITHM SUCCESSFULLY IDENTIFIES IMMUNOGENIC CANCER MUTATIONS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below